| Bilirubin-induced cell toxicity involves PTEN activation through an APE1/Ref-1-dependent pathway. | |
| | |
MedLine Citation:
|
PMID: 17479230 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Unconjugated bilirubin (UCB) is the major degradation product of the heme catabolism. A growing body of evidences suggests that UCB plays major biological effects by inhibiting cell proliferation in cancer cell lines and eliciting cell toxicity particularly in neurons and glial cells. Early molecular events responsible for bilirubin-induced cytotoxicity remain poorly understood. Using HeLa cells and mouse embryonic fibroblasts, we found that UCB at a concentration of free pigment (Bf) of 80 nM induced oxidative stress, promoting a significant increase in intracellular reactive oxygen species (ROS) and a decreased cell survival (by the MTT test). The ROS increase activated the antioxidant cell response through APE1/Ref-1, a master redox regulator in eukaryotic cells. Activation of APE1/Ref-1 was followed by a concomitant activation of Egr-1 transcription factor and by an upregulation of PTEN tumor suppressor, an Egr-1 target gene, leading to inhibition of cell growth. Blocking ROS generation with N-acetylcysteine pretreatment, restored cell survival, limited the upregulation of PTEN in response to UCB, and prevented the inhibition of cell proliferation. HeLa cells transfected with mutants of the PTEN promoter or silenced with APE1/Ref-1 small interference RNA confirmed that UCB modulates a signaling pathway involving APE1/Ref-1, Egr-1, and PTEN. These findings describe a new molecular pathway involved in the cytotoxic effects of UCB. |
| | |
Authors:
|
Laura Cesaratto; Sebastian D Calligaris; Carlo Vascotto; Marta Deganuto; Cristina Bellarosa; Franco Quadrifoglio; J Donald Ostrow; Claudio Tiribelli; Gianluca Tell |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2007-05-04 |
Journal Detail:
|
Title: Journal of molecular medicine (Berlin, Germany) Volume: 85 ISSN: 0946-2716 ISO Abbreviation: J. Mol. Med. Publication Date: 2007 Oct |
Date Detail:
|
Created Date: 2007-09-24 Completed Date: 2008-02-11 Revised Date: 2011-11-24 |
Medline Journal Info:
|
Nlm Unique ID: 9504370 Medline TA: J Mol Med (Berl) Country: Germany |
Other Details:
|
Languages: eng Pagination: 1099-112 Citation Subset: IM |
Affiliation:
|
Department of Biomedical Sciences and Technologies, University of Udine, 33100, Udine, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetylcysteine
/
metabolism Animals Apoptosis / drug effects Bilirubin / metabolism, toxicity* Cell Communication / drug effects, physiology Cell Differentiation / drug effects, physiology Cell Proliferation / drug effects Cell Survival / drug effects* DNA-(Apurinic or Apyrimidinic Site) Lyase / genetics, metabolism* Electrophoretic Mobility Shift Assay Enzyme Activation Fibroblasts / drug effects, metabolism Gene Expression Regulation* HeLa Cells / drug effects, metabolism Humans Mice PTEN Phosphohydrolase / genetics, metabolism* RNA, Small Interfering / genetics Reactive Oxygen Species / metabolism Transcription Factors / metabolism |
| Grant Support | |
ID/Acronym/Agency:
|
GGP05062//Telethon |
| Chemical | |
Reg. No./Substance:
|
0/RNA, Small Interfering; 0/Reactive Oxygen Species; 0/Transcription Factors; 616-91-1/Acetylcysteine; 635-65-4/Bilirubin; EC 3.1.3.67/PTEN Phosphohydrolase; EC 4.2.99.18/DNA-(Apurinic or Apyrimidinic Site) Lyase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Histamine-induced myosin light chain phosphorylation breaks down the barrier integrity of cultured c...
Next Document: Combined effect of mutations of the GH1 gene and its proximal promoter region in a child with growth...